DaShenLin Pharmaceutical Group Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 14,817.59 million compared to CNY 12,355.07 million a year ago. Revenue was CNY 14,817.59 million compared to CNY 12,355.07 million a year ago.

Net income was CNY 923.24 million compared to CNY 818.33 million a year ago. Basic earnings per share from continuing operations was CNY 0.8083 compared to CNY 0.7167 a year ago. Diluted earnings per share from continuing operations was CNY 0.8083 compared to CNY 0.7167 a year ago.